During the past decade, Charité Comprehensive Cancer Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Charité Comprehensive Cancer Center" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator and "Charite University, Berlin, Germany" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Charité Comprehensive Cancer Center" are "Carcinoma, Squamous Cell of Head and Neck" (1 trials), "Recurrent Head and Neck Cancer" (1 trials) and "Squamous Cell Carcinoma of the Head and Neck" (1 trials). Many other conditions were trialed in "Charité Comprehensive Cancer Center" in a lesser frequency.

Most popular intervention types in "Charité Comprehensive Cancer Center" are "Drug" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Amphinex induced PCI of bleomycin" (1 trials), "Durvalumab" (1 trials), "Radiotherapy" (1 trials) and "Tremelimumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Charité Comprehensive Cancer Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Charité Comprehensive Cancer Center". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Charité Comprehensive Cancer Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Charité Comprehensive Cancer Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".